Predictive Value of Preoperative Evaluation in Cases of Recurrent Endometriosis
1 other identifier
observational
64
1 country
1
Brief Summary
To investigate the effect of preoperative evaluation parameters in predicting recurrent disease in women who have undergone cystectomy or unilateral salpingo-oophorectomy due to endometriosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 22, 2022
CompletedFirst Submitted
Initial submission to the registry
November 7, 2023
CompletedFirst Posted
Study publicly available on registry
November 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedNovember 15, 2023
November 1, 2023
1.9 years
November 7, 2023
November 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction of endometriosis recurrence
Which women are more likely to have recurrence after endometriosis surgery?
6-180 months
Study Arms (2)
Remission group
Group of women who underwent cystectomy or unilateral oophorectomy due to endometriosis but were in remission during follow-up
Recurrent group
Group of women who underwent cystectomy or unilateral oophorectomy due to endometriosis but developed an endometrioma of at least 2 cm in size in a single ovary during follow-up.
Interventions
Cystectomy or unilateral oophorectomy due to endometriosis
Eligibility Criteria
All women between the ages of 18-50 who were followed up in our clinic after cystectomy or unilateral oophorectomy due to endometriosis.
You may qualify if:
- Women aged 18-50 who had a cystectomy or unilateral oophorectomy due to endometriosis
You may not qualify if:
- Women who have had bilateral oophorectomy due to endometriosis
- Malignant conditions
- Smoking
- Women with autoimmune disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bagcilar Teaching and Research Hospital
Istanbul, Bagcilar, 34200, Turkey (Türkiye)
Related Publications (1)
Hidari T, Hirata T, Arakawa T, Koga K, Neriishi K, Fukuda S, Nakazawa A, Nagashima N, Ma S, Sun H, Takamura M, Harada M, Hirota Y, Wada-Hiraike O, Fujii T, Osuga Y. Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy. BMC Womens Health. 2019 May 2;19(1):59. doi: 10.1186/s12905-019-0760-z.
PMID: 31046768RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Evrim Ebru Kovalak, MD
Bagcilar Training and Research Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor, gynecologist
Study Record Dates
First Submitted
November 7, 2023
First Posted
November 15, 2023
Study Start
February 22, 2022
Primary Completion
January 1, 2024
Study Completion
February 1, 2024
Last Updated
November 15, 2023
Record last verified: 2023-11